Please use this identifier to cite or link to this item: http://hdl.handle.net/10397/24779
DC FieldValueLanguage
dc.contributorDepartment of Applied Biology and Chemical Technology-
dc.creatorChao, J-
dc.creatorLau, WKW-
dc.creatorHuie, MJ-
dc.creatorHo, YS-
dc.creatorYu, MS-
dc.creatorLai, CSW-
dc.creatorWang, M-
dc.creatorYuen, WH-
dc.creatorLam, WH-
dc.creatorChan, TH-
dc.creatorChang, RCC-
dc.date.accessioned2015-06-23T09:07:34Z-
dc.date.available2015-06-23T09:07:34Z-
dc.identifier.issn0304-3940-
dc.identifier.urihttp://hdl.handle.net/10397/24779-
dc.language.isoenen_US
dc.publisherElsevieren_US
dc.subject6-Hydroxydopamineen_US
dc.subjectGreen tea polyphenols/EGCGen_US
dc.subjectNeuroprotectionen_US
dc.subjectProdrug/pEGCGen_US
dc.titleA pro-drug of the green tea polyphenol (-)-epigallocatechin-3-gallate (EGCG) prevents differentiated SH-SY5Y cells from toxicity induced by 6-hydroxydopamineen_US
dc.typeJournal/Magazine Articleen_US
dc.identifier.spage360-
dc.identifier.epage364-
dc.identifier.volume469-
dc.identifier.issue3-
dc.identifier.doi10.1016/j.neulet.2009.12.028-
dcterms.abstractRegular consumption of green tea benefits people in prevention from cardiovascular disorders, obesity as well as neurodegenerative diseases. (-)-Epigallocatechin-3-gallate (EGCG) is regarded as the most biologically active catechin in green tea. However, the stability and bioavailability of EGCG are restricted. The purpose of the present study was to investigate whether a pro-drug, a fully acetylated EGCG (pEGCG), could be more effective in neuroprotection in Parkinsonism mimic cellular model. Retinoic acid (RA)-differentiated neuroblastoma SH-SY5Y cells were pre-treated with different concentrations of EGCG and pEGCG for 30 min and followed by incubation of 25 μM 6-hydroxydopamine (6-OHDA) for 24 h. We found that a broad dosage range of pEGCG (from 0.1 to 10 μM) could significantly reduce lactate dehydrogenase release. Likewise, 10 μM of pEGCG was effective in reducing caspase-3 activity, while EGCG at all concentrations tested in the model failed to attenuate caspase-3 activity induced by 6-OHDA. Furthermore, Western-blot analysis showed that Akt could be one of the specific signaling pathways stimulated by pEGCG in neuroprotection. It was demonstrated that 25 μM of 6-OHDA significantly suppressed the phosphorylation level of Akt. Only pEGCG at 10 μM markedly increased its phosphorylation level compared to 6-OHDA alone. Taken together, as pEGCG has higher stability and bioavailbility for further investigation, it could be a potential neuroprotective agent and our current findings may offer certain clues for optimizing its application in future.-
dcterms.bibliographicCitationNeuroscience letters, 2010, v. 469, no. 3, p. 360-364-
dcterms.isPartOfNeuroscience letters-
dcterms.issued2010-
dc.identifier.isiWOS:000274722100017-
dc.identifier.scopus2-s2.0-73849147183-
dc.identifier.pmid20026175-
dc.identifier.eissn1872-7972-
dc.identifier.rosgroupidr46461-
dc.description.ros2009-2010 > Academic research: refereed > Publication in refereed journal-
Appears in Collections:Journal/Magazine Article
Access
View full-text via PolyU eLinks SFX Query
Show simple item record

SCOPUSTM   
Citations

40
Last Week
0
Last month
0
Citations as of Jun 30, 2020

WEB OF SCIENCETM
Citations

37
Last Week
0
Last month
1
Citations as of Jul 9, 2020

Page view(s)

107
Last Week
0
Last month
Citations as of Feb 11, 2020

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.